The Australian-founded biotechnology company is progressing three investigational treatments, including a synthetic psilocybin therapy for generalised anxiety disorder, as its ...
Australia has earned global recognition for its role in the emerging psychedelic medicines sector. The country's decision to permit authorised ...
From Melbourne Cannabis Startup to NASDAQ Biotech Contender When historians eventually document Australia's contribution to the modern psychedelic medicine movement, ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
